Signaling Protein Networks as Targets of New Antineoplastic Drugs
نویسندگان
چکیده
منابع مشابه
Astrocytes as new targets for antiepileptic drugs
Epilepsy is a disorder of the brain characterised by un-provoked, recurrent seizures and affects about 1% of the population worldwide. A deeper understanding of the cellular basis of the epilepsies would be essential for the identification of novel targets for therapeutic intervention. Since neuronal hyperexcitation and hypersynchronization are hallmarks of epilepsy, the search for new antiepil...
متن کاملStudy of PKA binding sites in cAMP-signaling pathway using structural protein-protein interaction networks
Backgroud: Protein-protein interaction, plays a key role in signal transduction in signaling pathways. Different approaches are used for prediction of these interactions including experimental and computational approaches. In conventional node-edge protein-protein interaction networks, we can only see which proteins interact but ‘structural networks’ show us how these proteins inter...
متن کاملRegional Administration of Antineoplastic Drugs
Regional antineoplastic drug delivery is not a new concept. Following the initial recognition that cytotoxic alkylating agents could cause shrinkage of tumor masses and a reduction in the quantity of malignant ascites in patients with advanced ovarian cancer, investigators in the 1950s instilled the drugs directly into the peritoneal cavity in an effort to treat the malignancy (1). Similarly, i...
متن کاملSulfa Drugs as Inhibitors of Carbonic Anhydrase: New Targets for the Old Drugs
Sulfa drugs are well-known antibacterial agents containing N-substituted sulfonamide group on para position of aniline ring (NH2RSO2NHR'). In this study 2,4-dichloro-1,3,5-triazine derivatives of sulfa drugs, sulfamerazine (1b), sulfaquinoxaline (2b), sulfadiazine (3b), sulfadimidine (4b), and sulfachloropyrazine (5b) (1a-5a) were synthesized and characterized. Their carbonic anhydrase inhibiti...
متن کاملG-protein-coupled receptors as signaling targets for antiplatelet therapy.
Platelet G protein-coupled receptors (GPCRs) initiate and reinforce platelet activation and thrombus formation. The clinical utility of antagonists of the P2Y(12) receptor for ADP suggests that other GPCRs and their intracellular signaling pathways may represent viable targets for novel antiplatelet agents. For example, thrombin stimulation of platelets is mediated by 2 protease-activated recep...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The International Journal of Biological Markers
سال: 2003
ISSN: 1724-6008,1724-6008
DOI: 10.1177/172460080301800110